The bar chart illustrates the percentage distribution of a drug company’s total sales across three regions — Asia, Europe, and America — over a five-year period from 2002 to 2006.
Overall, Asia saw a consistent increase in its share of sales, while America’s share declined notably. Europe’s contribution fluctuated slightly but remained relatively stable throughout the period.
In 2002, America accounted for the largest portion of the company’s sales at 41%, followed by Europe at 34%, and Asia at only 25%. However, over the next four years, the proportion of sales from America steadily decreased, dropping to 30% by 2006. In contrast, Asia experienced significant growth, rising from 25% in 2002 to become the leading region with 40% in 2006.
Europe’s share began at 34% in 2002 and showed modest variation, peaking at 38% in 2004 and then gradually decreasing to 30% by 2006. This pattern indicates that while Europe maintained a fairly even presence in the company’s sales, the dominant market shifted from America to Asia over the observed period.
In summary, the chart highlights a clear shift in market dominance from America to Asia, with Europe remaining a steady but secondary contributor to total sales.